Boston Scientific (BSX) Stock Buyback History
TTM buyback yield N/A.
TTM buyback yield
N/A
Shareholder yield (TTM)
N/A
5Y share count change
5.5%
TTM buyback spend
N/A
SBC coverage (TTM)
0.00x
Diluted vs basic shares (annual)
Weighted average shares from the income statement: diluted (EPS denominator and typical buyback-yield basis) compared with basic.
Shares outstanding (annual)
Year-over-year change in diluted weighted average shares (industry-standard for EPS and per-share capital return). Green is fewer shares vs the prior fiscal year; red is growth (dilution). The earliest year shown has no prior year to compare.
Dividend & buyback yield
Buybacks vs stock-based compensation
TTM coverage: 0.00x (buybacks ÷ SBC). Bars are fiscal-year totals.
Buyback spending history
| Year | Buybacks | SBC | Net | Shares (dil.) | YoY shares | Buyback yield |
|---|---|---|---|---|---|---|
| 2025 | $0.00 | $299.00M | −$299.00M | 1.49B | 0.6% | — |
| 2024 | $0.00 | $266.00M | −$266.00M | 1.49B | 1.5% | — |
| 2023 | $0.00 | $233.00M | −$233.00M | 1.46B | 1.7% | — |
| 2022 | $136.00M | $220.00M | −$84.00M | 1.44B | 0.4% | 0.21% |
| 2021 | $0.00 | $194.00M | −$194.00M | 1.43B | 1.2% | — |
| 2020 | $535.00M | $170.00M | $365.00M | 1.42B | 0.4% | 1.04% |
| 2019 | $0.00 | $157.00M | −$157.00M | 1.41B | 0.7% | — |
| 2018 | $0.00 | $140.00M | −$140.00M | 1.40B | 0.6% | — |
| 2017 | $0.00 | $127.00M | −$127.00M | 1.39B | 1.1% | — |
| 2016 | $0.00 | $116.00M | −$116.00M | 1.38B | 2.7% | — |
| 2015 | $0.00 | $107.00M | −$107.00M | 1.34B | -0.5% | — |
| 2014 | $125.00M | $103.00M | $22.00M | 1.35B | 0.5% | 0.71% |
| 2013 | $500.00M | $105.00M | $395.00M | 1.34B | -4.7% | 3.13% |
| 2012 | $600.00M | $108.00M | $492.00M | 1.41B | -7.4% | 7.67% |
| 2011 | $492.00M | $128.00M | $364.00M | 1.52B | 0.1% | 6.38% |
| 2010 | $0.00 | $150.00M | −$150.00M | 1.52B | 0.7% | — |
| 2009 | $0.00 | $144.00M | −$144.00M | 1.51B | 0.6% | — |
| 2008 | $0.00 | $138.00M | −$138.00M | 1.50B | 0.8% | — |
| 2007 | $60.00M | $122.00M | −$62.00M | 1.49B | 16.7% | 0.35% |
| 2006 | $0.00 | $0.00 | $0.00 | 1.27B | 52.1% | — |
| 2005 | $734.00M | $0.00 | $734.00M | 0.84B | -2.2% | 3.61% |
| 2004 | $360.00M | $0.00 | $360.00M | 0.86B | 1.6% | 1.22% |
| 2003 | $570.00M | $0.00 | $570.00M | 0.84B | 1.7% | 1.84% |
| 2002 | $0.00 | $0.00 | $0.00 | 0.83B | -0.2% | — |
| 2001 | $0.00 | $0.00 | $0.00 | 0.83B | 1.3% | — |
| 2000 | $222.00M | $0.00 | $222.00M | 0.82B | -0.6% | — |
| 1999 | $127.00M | $0.00 | $127.00M | 0.82B | 6.2% | — |
| 1998 | $0.00 | $0.00 | $0.00 | 0.78B | -2.9% | — |
| 1997 | $187.00M | $0.00 | $187.00M | 0.80B | 0.5% | — |
| 1996 | $63.80M | $0.00 | $63.80M | 0.80B | — | — |
| 1995 | $0.00 | $0.00 | $0.00 | — | — | — |
| 1994 | $0.00 | $0.00 | $0.00 | — | — | — |
| 1993 | $57.40M | $0.00 | $57.40M | — | — | — |
| 1992 | $0.00 | $0.00 | $0.00 | — | — | — |
| 1991 | $0.00 | $0.00 | $0.00 | — | — | — |
Buybacks vs dividends (share of cash returned)
Buyback capacity (TTM)
TTM buybacks vs headroom (FCF − dividends, TTM)0% of headroom
Headroom $3.63B (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Does Boston Scientific buy back its own stock?
- Yes, Boston Scientific (BSX) has repurchased shares in recent periods. See the history table and charts on this page for amounts and trends.
Is Boston Scientific diluting shareholders?
- Compare stock-based compensation (SBC) to buybacks in the chart above. Net effect varies by year; see annual buyback vs SBC bars and the history table.
How has Boston Scientific's share count changed?
- Diluted weighted average shares changed by about 5.5% over roughly five fiscal years (annual income statement data).